Literature DB >> 32007194

Chemotherapy for resectable microsatellite instability-high gastric cancer?

Elizabeth C Smyth.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32007194     DOI： 10.1016/S1470-2045(20)30025-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

1.  Blood alkaline phosphatase predicts prognosis of patients with advanced HER2-negative gastric cancer receiving immunotherapy.

Authors:  Jianli Hu; Shengli Yang; Jing Wang; Qiuyue Zhang; Lei Zhao; Dejun Zhang; Dandan Yu; Min Jin; Hong Ma; Hongli Liu; Jun Xue; Tao Zhang
Journal:  Ann Transl Med       Date:  2021-08

Review 2.  Biomarkers for Precision Treatment in Gastric Cancer.

Authors:  Angelica Petrillo; Elizabeth C Smyth
Journal:  Visc Med       Date:  2020-09-25

Review 3.  Progress of Gastric Cancer Surgery in the era of Precision Medicine.

Authors:  Yumin Wang; Luyuan Zhang; Yi Yang; Shan Lu; Hao Chen
Journal:  Int J Biol Sci       Date:  2021-03-02       Impact factor: 6.580

4.  Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials.

Authors:  Hedde D Biesma; Tanya T D Soeratram; Karolina Sikorska; Irene A Caspers; Hendrik F van Essen; Jacqueline M P Egthuijsen; Aart Mookhoek; Hanneke W M van Laarhoven; Mark I van Berge Henegouwen; Marianne Nordsmark; Donald L van der Peet; Fabienne A R M Warmerdam; Maud M Geenen; Olaf J L Loosveld; Johanneke E A Portielje; Maartje Los; Daniëlle A M Heideman; Elma Meershoek-Klein Kranenbarg; Henk H Hartgrink; Johanna van Sandick; Marcel Verheij; Cornelis J H van de Velde; Annemieke Cats; Bauke Ylstra; Nicole C T van Grieken
Journal:  Gastric Cancer       Date:  2022-02-07       Impact factor: 7.701
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.